Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

March 26, 2015 - 2:00 a.m.
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Sovaldi® (sofosbuvir) for the Treatment of Genotype 2 Chronic Hepatitis CPrinter Friendly Version 
March 10, 2015 - 5:00 p.m.
Gilead Sciences to Present at the Barclays Global Healthcare Conference on Wednesday, March 11Printer Friendly Version 

Upcoming Events

Wednesday, April 22, 2015 through Sunday, April 26, 2015
50th Annual Meeting of the European Association for the Study of the Liver (EASL): The International Liver Congress 2015
LocationVienna, Austria
Wednesday, May 6, 2015
Gilead Sciences 2015 Annual Stockholders Meeting
LocationMillbrae, CA

Most Viewed Links

Updated 01/31/15
2.SEC Filings
3.Stock Information
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 01/23/15 - 01/30/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Down 0.08 (0.08%)
Data as of 03/27/15 4:15 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Fourth Quarter 2014 Gilead Sciences Earnings Conference Call

February 03, 2015 1:30 p.m. PT